「ag」の検索結果
43件：1～5件目を表示
-
お知らせ | 千寿製薬株式会社
a BAC-free formulation of Aibeta® combination eye drops（PDF） 2025年03月07日 Announcement of Licensing Agreement with Brill International（PDF） 2025年02月20日 Launch and Distribution of “MIEr for BeelineMED”...
https://www.senju.co.jp/chinese/news/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Ats...
https://www.senju.co.jp/english/rd/society/ -
therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) *1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition ...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) *1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition ...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf